Gabusectin derivatives, method for the production thereof and use of the same

Details for Australian Patent Application No. 2002366191 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Schiell, Matthias; Toti, Luigi; MarkusErb, Astrid; Knauf, Martin

Agent Watermark

Pub. Number AU-B-2002366191

PCT Number PCT/EP02/12420

PCT Pub. Number WO2003/043984

Priority 101 56 906.8 21.11.01 DE

Filing date 7 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 31 January 2008

International Classifications

C07D 207/44 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 101 56 906.8 21.11.01 DE

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002366191

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH 2003

31 January 2008 Application Accepted

  Published as AU-B-2002366191

29 May 2008 Standard Patent Sealed

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002366192-DERIVATIVES OF ANDRIMIDE AND MOIRAMIDE B HAVING ANTIBACTERIAL PROPERTIES

2002366190-OPTOELECTRICAL TRANSCEIVER